olmesartan has been researched along with Hyperpotassemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garland, K; Rishi, A | 1 |
| Chan, JC; Haneda, M; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T | 1 |
1 trial(s) available for olmesartan and Hyperpotassemia
| Article | Year |
|---|---|
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Stroke; Tetrazoles; Treatment Outcome | 2011 |
1 other study(ies) available for olmesartan and Hyperpotassemia
| Article | Year |
|---|---|
Unusual Severe Side Effect of a Commonly Used Drug.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Humans; Hyperkalemia; Hypertension; Imidazoles; Male; Severity of Illness Index; Tetrazoles | 2016 |